RYTHMOL

This brand name is authorized in United States. It is also authorized in Canada, France, South Africa.

Active ingredients

The drug RYTHMOL contains one active pharmaceutical ingredient (API):

1	Propafenone UNII 33XCH0HOCD - PROPAFENONE HYDROCHLORIDE
	Propafenone is a class IC anti-arrhythmic agent. It has a stabilising action on myocardial membranes, reduces the fast inward current carried by sodium ions with a reduction in depolarisation rate and prolongs the impulse conduction time in the atrium, AV node and primarily, in the His-Purkinje system.
	Read more about Propafenone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
RYTHMOL SR Capsule	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C01BC03	Propafenone	C Cardiovascular system → C01 Cardiac therapy → C01B Antiarrhythmics, class I and III → C01BC Antiarrhythmics, class Ic
Discover more medicines within C01BC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	00603708, 00603716
FR	Base de données publique des médicaments	66843923
US	FDA, National Drug Code	0173-0823, 0173-0824, 0173-0826
ZA	Health Products Regulatory Authority	R/6.2/149, R/6.2/150